Genomics

Dataset Information

0

Affymetrix SNP array data for chronic lymphocytic leukemia samples


ABSTRACT: Although in 80% of CLL cases that require therapy is possible to achieve a complete remission using a combination of fludarabine, anti-CD20 in conjunction with cyclophosphamide and/or mitoxantrone, 20% of patients do not achieve disease control with this conventional approach. The main reason of complete remission failure is chemorefractoriness to fludarabine that occurs in up to 10% of patients requiring treatment. In order to identify new molecular predictors of refractoriness as well as druggable therapeutic targets, we combined next-generation sequencing and copy number analyses. Affymetrix SNP array analysis was performed according to the manufacturer's directions on DNA extracted from cryopreserved diagnostic samples.

ORGANISM(S): Homo sapiens

PROVIDER: GSE51711 | GEO | 2014/04/30

SECONDARY ACCESSION(S): PRJNA224700

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2014-04-30 | E-GEOD-51711 | biostudies-arrayexpress
2017-04-10 | GSE95690 | GEO
2020-01-01 | GSE130874 | GEO
2020-10-27 | GSE150930 | GEO
2013-09-17 | E-GEOD-42056 | biostudies-arrayexpress
2014-09-01 | GSE54201 | GEO
2016-03-29 | GSE74555 | GEO
2014-09-01 | E-GEOD-54201 | biostudies-arrayexpress
2024-05-26 | GSE267970 | GEO
2021-06-09 | GSE165087 | GEO